Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03777917 · ClinicalTrials.gov registry record · NA
A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow
A NA study of Correction of Volume Loss in the Infraorbital Hollow Area, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 3
- Study locations
NCT03777917 is a NA study of Correction of Volume Loss in the Infraorbital Hollow Area that has completed, run by Merz North America. The registered enrollment target is 66 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT03777917, a NA study of Correction of Volume Loss in the Infraorbital Hollow Area, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 3
- Study locations
Study Summary
The pilot study aims to define safety, effectiveness, and patient-reported outcomes for Belotero Balance® use in the infraorbital hollows.
Conditions Studied
Interventions
- DEVICE Belotero Balance®
Study Locations (3)
Florida
- Center for Sight, Merz Investigational Site #0010414 - Sarasota
New York
- Private Practice, Merz Investigational Site #0010413 - New York
Tennessee
- Center for Laser and Facial Surgery, Merz Investigational Site #0010353 - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-12-27 |
| Est. Completion | 2020-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03777917
The ClinicalTrials.gov registry entry for NCT03777917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Correction of Volume Loss in the Infraorbital Hollow Area appearing as the primary indexed condition, and to 1 intervention - of which Belotero Balance® is the first listed.
NCT03777917 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New York, Tennessee.
Frequently Asked Questions
What is clinical trial NCT03777917 about?
NCT03777917 is a clinical study titled "A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow". The pilot study aims to define safety, effectiveness, and patient-reported outcomes for Belotero Balance® use in the infraorbital hollows.
What is the current status of trial NCT03777917?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2018-12-27. Estimated completion is 2020-03-11.
What conditions does trial NCT03777917 study?
This clinical trial studies the following conditions: Correction of Volume Loss in the Infraorbital Hollow Area.
What interventions are being tested in trial NCT03777917?
The interventions under investigation include: Belotero Balance® (DEVICE).
Who is sponsoring clinical trial NCT03777917?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03777917 being conducted?
This trial has 3 study locations across Florida, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.